Ashita Tolwani, MD
Professor of Medicine
University of Alabama at Birmingham
Explains how CRRT prescription might need to be adjusted in regards to modality, dose, and anticoagulation for AKI patients with COVID-19.
Ashita Tolwani, MD
Professor of Medicine
University of Alabama at Birmingham
Explains how CRRT prescription might need to be adjusted in regards to modality, dose, and anticoagulation for AKI patients with COVID-19.
Read more: https://www.youtube.com/watch?v=TTJHB4JUpoE
WELCOME TO RENAL MEDCASE – A KIDNEYTUBE CHANNEL MEMBER